• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, November 22, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Different bacteria use same cell surface molecule to invade tissue and promote infection

Bioengineer by Bioengineer
March 19, 2019
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Blocking bacteria-molecule interaction might prevent many deadly illnesses

IMAGE

Credit: Patrick Schlievert, Ph.D., University of Iowa Carver College of Medicine

A new study identifies a single molecule as a key entry point used by two types of dangerous bacteria to break through cellular barriers and cause disease. The findings, published March 19 in the journal mBio, suggest that blocking the interaction between the molecule, known as CD40, and bacteria may represent a universal strategy for preventing life-threatening illnesses, including toxic shock syndrome.

The two bacteria, Staphylococcus aureus (staph) and Streptococcus pyogenes, cause many serious illnesses. According to the Centers for Disease Control and Prevention, staph causes 70,000 cases of highly fatal pneumonia, 40,000 cases of severe heart infections, and over 500,000 post-surgical infections each year. Streptococcus pyogenes causes 10 million cases of sore throat and 30,000 cases of severe invasive diseases annually.

“Many of the infections caused by these two bacteria start on the skin or on the mucosal surfaces that line body cavities like the nose, mouth and throat, the gut, and the vagina. The ability of these bacteria to cause disease depends on production of a family of toxins known as superantigens, which cause exceptionally harmful inflammation,” explains Patrick Schlievert, PhD, professor and head of microbiology and immunology at the University of Iowa Carver College of Medicine and lead author of the new study.

Previous work by Schlievert showed that superantigens cause the epithelial cells of the mucosal barrier to make signaling molecules called chemokines. Those chemokines attract immune cells that disrupt the integrity of the mucosal barrier, allowing the superantigens and frequently the bacteria themselves to penetrate and cause serious and often fatal diseases, including toxic shock syndrome.

In the new study, Schlievert and his colleagues at the UI and National Jewish Health in Denver used human vaginal epithelial cells as a model of a mucosal barrier. They showed that the interaction between CD40 and superantigens triggers the production of chemokines in these cells. Removing CD40 from the cells using CRISPR gene editing prevented bacterial superantigens from triggering the production of the chemokines. In contrast, restoring CD40 to those cells restored the ability of superantigens to trigger chemokine production.

The team tested three superantigens: toxic shock syndrome toxin 1 (TSST-1), and staphylococcal enterotoxin B and C. Of the three, TSST-1 produced the strongest effect, which likely explains why this superantigen is responsible for all cases of menstrual toxic shock syndrome.

“CD40 is critical; you get no response (to the superantigens) without it,” Schlievert says. “Since we now know that these two large families of bacteria cause disease through the same human tissue receptor, we are looking for ways to block the interaction between CD40 and superantigens to prevent immune activation. This work also raises the possibility that many other pathogens may cause diseases through the same receptor interaction. Those studies are underway.

“If there is a central pathway that many pathogens use to disrupt mucosal barriers, that would mean we have a single target to block to prevent barrier disruption by pathogens. That could be huge,” he adds.

###

In addition to Schlievert, the research team included UI researchers Michael Cahill, Bruce Hostager, Aloysius Klingelhutz, Francoise Gourronc, and Gail Bishop; Amanda Brosnahan at the University of Minnesota; and Donald Y. M. Leung at National Jewish Health in Denver.

The study was funded in part by grants from the National Institutes of Health.

Media Contact
Jennifer Brown
jennifer-l-brown@uiowa.edu

Original Source

https://medicine.uiowa.edu/content/study-identifies-molecule-allows-bacteria-breach-cellular-barriers

Related Journal Article

http://dx.doi.org/10.1128/mBio.00214-19

Tags: Immunology/Allergies/AsthmaInfectious/Emerging DiseasesMedicine/HealthUrogenital System
Share12Tweet8Share2ShareShareShare2

Related Posts

Mouse Models of TDP-43 Proteinopathies Show Divergent Early Glial Activation Patterns

Mouse Models of TDP-43 Proteinopathies Show Divergent Early Glial Activation Patterns

November 22, 2026
Cognitive Flexibility and Fertility Awareness Linked to Contraceptive Intentions in Women

Cognitive Flexibility and Fertility Awareness Linked to Contraceptive Intentions in Women

November 22, 2026

Causal Forest Machine Learning Model Identifies Divergent Corticosteroid Outcomes in Hospitalized Veterans

November 22, 2026

Lower Circulating Immunosurveillance Proteins Are Linked to Higher Prostate Cancer Risk

November 22, 2026
Please login to join discussion

POPULAR NEWS

  • Analysis Links Ganoderma Lucidum Target NR3C2 and Gut Microbiota to Insomnia

    Analysis Links Ganoderma Lucidum Target NR3C2 and Gut Microbiota to Insomnia

    29 shares
    Share 12 Tweet 7
  • THAM Catalyzes Efficient Green Gewald Synthesis of Diverse 2-Aminothiophene Heterocycles

    29 shares
    Share 12 Tweet 7
  • Waste Glass and Sisal Fibers Increase Concrete Strengths in Neural Network Study

    29 shares
    Share 12 Tweet 7
  • Cementless Megaprosthesis Achieves Favorable Long-Term Stability After Bone Tumor Resection

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mouse Models of TDP-43 Proteinopathies Show Divergent Early Glial Activation Patterns

Cognitive Flexibility and Fertility Awareness Linked to Contraceptive Intentions in Women

Novel Probe Cell Accelerates Localized Testing of Fuel Cell Catalyst Layers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.